219 related articles for article (PubMed ID: 10953915)
1. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
Harries M; Phillipps N; Anderson R; Prentice G; Collins M
J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
[TBL] [Abstract][Full Text] [Related]
2. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
3. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
[TBL] [Abstract][Full Text] [Related]
4. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo comparison of viral and cellular internal ribosome entry sites for bicistronic vector expression.
Licursi M; Christian SL; Pongnopparat T; Hirasawa K
Gene Ther; 2011 Jun; 18(6):631-6. PubMed ID: 21368899
[TBL] [Abstract][Full Text] [Related]
6. Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site.
Kobayashi T; Kida Y; Kaneko T; Pastan I; Kobayashi K
J Gene Med; 2001; 3(5):505-10. PubMed ID: 11601764
[TBL] [Abstract][Full Text] [Related]
7. Development of a new bicistronic retroviral vector with strong IRES activity.
Martin P; Albagli O; Poggi MC; Boulukos KE; Pognonec P
BMC Biotechnol; 2006 Jan; 6():4. PubMed ID: 16409632
[TBL] [Abstract][Full Text] [Related]
8. Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.
Delluc-Clavières A; Le Bec C; Van den Berghe L; Conte C; Allo V; Danos O; Prats AC
Gene Ther; 2008 Aug; 15(15):1090-8. PubMed ID: 18369321
[TBL] [Abstract][Full Text] [Related]
9. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H
Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254
[TBL] [Abstract][Full Text] [Related]
10. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
11. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
Fu J; Chen Z; Wang W
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.
Zitvogel L; Tahara H; Cai Q; Storkus WJ; Muller G; Wolf SF; Gately M; Robbins PD; Lotze MT
Hum Gene Ther; 1994 Dec; 5(12):1493-506. PubMed ID: 7711142
[TBL] [Abstract][Full Text] [Related]
14. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
Byun J; Kim JM; Robbins PD; Kim S
Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
[TBL] [Abstract][Full Text] [Related]
15. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
[TBL] [Abstract][Full Text] [Related]
16. Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes.
Wong ET; Ngoi SM; Lee CG
Gene Ther; 2002 Mar; 9(5):337-44. PubMed ID: 11938453
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer.
Pizzato M; Franchin E; Calvi P; Boschetto R; Colombo M; Ferrini S; Palù G
Gene Ther; 1998 Jul; 5(7):1003-7. PubMed ID: 9813672
[TBL] [Abstract][Full Text] [Related]
18. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
19. Dicistronic polioviruses as expression vectors for foreign genes.
Alexander L; Lu HH; Gromeier M; Wimmer E
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S57-60. PubMed ID: 7865334
[TBL] [Abstract][Full Text] [Related]
20. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
